Epilepsy research program(ERP) meeting support services
Ended Awarded Last action
- Contract number
- W81XWH20F0213
- Awardee
-
Leidos, Inc. UEI QLNMVC12KWY3 Part of Leidos Holdings, Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $314,560
Award facts
- Opportunity
-
- W81XWH17R0036 Solicitation number
- Meeting, Scientific and Administrative Support Services (MSASS), Request for Proposal (RFP) Award Notice · Posted Apr 12, 2017
- Meeting, Scientific and Administrative Support Services Award Notice · Posted Mar 22, 2017
- Contract value 96% obligated
-
- $314,560.37 Current, with exercised options
- $328,710.72 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Medical Command Department of the Army, Department of Defense
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Two Step
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$4,150 | |
| Supplemental Agreement for work within scope | $4,820 | |
| Funding Only Action | $51,997 | |
| Exercise an Option | $56,415 | |
| Funding Only Action | $34,777 | |
| Funding Only Action | $17,274 | |
| Exercise an Option | $56,486 | |
| Original award | $96,942 |
About this award
Leidos, Inc., through its Leidos Services Operating Segment Division, was awarded a $328,710.72 delivery order on July 1, 2020, to provide fiscal year 2022 Epilepsy Research Program (ERP) meeting support services for the Defense Health Agency's Medical Command. The contract, which employed a cost-plus-fixed-fee pricing structure with no set-aside designation, was performed in Frederick, Maryland, and completed by June 30, 2023. This delivery order supported the congressionally directed medical research initiatives administered through the Defense Health Agency, which funds innovative research aimed at advancing treatments and understanding of epilepsy and related neurological conditions affecting military personnel and the broader population.
The award reflects Leidos' extensive experience in administering and supporting federally funded medical research programs within the Department of Defense health portfolio. As a major federal contractor with substantial indefinite delivery contracts valued at over $100 million with the Naval Health Research Center for non-personal research and development services, Leidos has demonstrated capability in managing complex medical research administrative functions, including conference organization, logistics coordination, and program support services essential to advancing the Defense Health Agency's research mission objectives.
Quick answers
Who was awarded contract W81XWH20F0213?
W81XWH20F0213 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on July 1, 2020.
How much is contract W81XWH20F0213 worth?
The government has obligated $314,560 on W81XWH20F0213. Its potential value, with all options, is $328,711.
Which agency awarded contract W81XWH20F0213?
Defense Health Agency (Department of Defense) awarded W81XWH20F0213, with funding from Medical Command (Department of the Army).
Is contract W81XWH20F0213 an order under another contract?
Yes. W81XWH20F0213 is a delivery order under W81XWH17D0025, an indefinite delivery contract.
Was contract W81XWH20F0213 competed?
The extent of competition for W81XWH20F0213 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award